These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31595633)

  • 1. Improvement in processing speed following haploidentical bone marrow transplant with posttransplant cytoxan in children and adolescents with sickle cell disease.
    Prussien KV; Patel DA; Wilkerson K; Armstrong B; Karnik L; de la Fuente J; Kassim AA
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28001. PubMed ID: 31595633
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.
    Bolaños-Meade J; Fuchs EJ; Luznik L; Lanzkron SM; Gamper CJ; Jones RJ; Brodsky RA
    Blood; 2012 Nov; 120(22):4285-91. PubMed ID: 22955919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update.
    Patel DA; Akinsete AM; de la Fuente J; Kassim AA
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):91-97. PubMed ID: 32202252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative.
    de la Fuente J; Dhedin N; Koyama T; Bernaudin F; Kuentz M; Karnik L; Socié G; Culos KA; Brodsky RA; DeBaun MR; Kassim AA
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1197-1209. PubMed ID: 30500440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up.
    Hernigou P; Bernaudin F; Reinert P; Kuentz M; Vernant JP
    J Bone Joint Surg Am; 1997 Nov; 79(11):1726-30. PubMed ID: 9384433
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage activation syndrome and post-transplant microangiopathy following haploidentical bone marrow transplantation for sickle cell anemia.
    Davies JOJ; Hart AC; De La Fuente J; Bain BJ
    Am J Hematol; 2018 Aug; 93(4):588-589. PubMed ID: 29197110
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
    McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
    Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia.
    Chellapandian D; Nicholson CL
    Pediatr Transplant; 2020 Feb; 24(1):e13641. PubMed ID: 31880407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
    Bonfim C; Ribeiro L; Nichele S; Loth G; Bitencourt M; Koliski A; Kuwahara C; Fabro AL; Pereira NF; Pilonetto D; Thakar M; Kiem HP; Page K; Fuchs EJ; Eapen M; Pasquini R
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):310-317. PubMed ID: 27832981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.
    Knüppel E; Medinger M; Stehle G; Infanti L; Halter J; Burkhalter F; Mujagic E; Heim D; Passweg J
    Ann Hematol; 2017 Apr; 96(4):703-705. PubMed ID: 28160086
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease.
    Pawlowska AB; Cheng JC; Karras NA; Sun W; Wang LD; Bell AD; Gutierrez L; Rosenthal J
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):185-189. PubMed ID: 28939451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia.
    Walters MC; Sullivan KM; Bernaudin F; Souillet G; Vannier JP; Johnson FL; Lenarsky C; Powars D; Bunin N; Ohene-Frempong K
    Blood; 1995 Feb; 85(4):879-84. PubMed ID: 7849310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue.
    Ghavamzadeh A; Alimoghaddam K; Jalili M; Mousavi SA; Bahar B; Kasaeian A; Hamidieh AA; Behfar M; Vaezi M; Jalali A; Jahani M
    Bone Marrow Transplant; 2016 Dec; 51(12):1628-1630. PubMed ID: 27668763
    [No Abstract]   [Full Text] [Related]  

  • 15. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.
    Walters MC; Patience M; Leisenring W; Rogers ZR; Aquino VM; Buchanan GR; Roberts IA; Yeager AM; Hsu L; Adamkiewicz T; Kurtzberg J; Vichinsky E; Storer B; Storb R; Sullivan KM;
    Biol Blood Marrow Transplant; 2001; 7(12):665-73. PubMed ID: 11787529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.
    Frangoul H; Evans M; Isbell J; Bruce K; Domm J
    Bone Marrow Transplant; 2018 May; 53(5):647-650. PubMed ID: 29339800
    [No Abstract]   [Full Text] [Related]  

  • 17. [Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Dubois V; Amokrane K; Beguin Y; Bruno B; Chevallier P; Delbos F; Devillier R; Giannoli C; Guidicelli G; Harif M; Loiseau P; Rouzaire PO; Varlet P; Yakoub-Agha I; Nguyen S
    Bull Cancer; 2020 Jan; 107(1S):S72-S84. PubMed ID: 31586527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions.
    Hansbury EN; Schultz WH; Ware RE; Aygun B
    Pediatr Blood Cancer; 2012 Apr; 58(4):611-5. PubMed ID: 22435112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of graft rejection after bone marrow transplant in thalassemia.
    Galimberti M; Andreani M; Lucarelli G; Centis F; Filocamo M; Polchi P; Manenti F; Agostinelli F; Giorgi C; Filippetti A
    Prog Clin Biol Res; 1989; 309():223-9. PubMed ID: 2675090
    [No Abstract]   [Full Text] [Related]  

  • 20. Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India.
    Uppuluri R; Sivasankaran M; Patel S; Swaminathan VV; Ramanan KM; Ravichandran N; Ramakrishnan B; Jayakumar I; Vaidhyanathan L; Raj R
    J Clin Immunol; 2019 Feb; 39(2):182-187. PubMed ID: 30778805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.